-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Asthma is a common chronic respiratory disease with more than 300 million patients worldwide and a serious threat to human health
On March 25, 2022, Professor Qian Feng's research group from the School of Pharmacy, Shanghai Jiao Tong University published a long article titled AMFR drives allergic asthma development by promoting alveolar macrophage in the Journal of Experimental Medicine (IF=14.
Research Introduction
The autocrine motility factor receptor (AMFR), also known as gp78, is an endoplasmic reticulum-resident E3 ubiquitin ligase that recognizes misfolded proteins, ubiquitinates them, and ubiquitinates them.
In this study, the researchers analyzed the differential genes in AMs of asthma model mice by whole-genome sequencing, and found for the first time that the expression of Amfr gene was specifically up-regulated in AMs
Summarize
Alarmin TSLP is a novel drug target for the treatment of asthma.
Professor Qian Feng and Associate Researcher Sun Lei from the School of Pharmacy, Shanghai Jiao Tong University are the co-corresponding authors of the paper, and Zhang Huihui, a doctoral student from the School of Pharmacy, Shanghai Jiao Tong University, is the first author of the paper
Link to the paper : https://rupress.